Unbiased AI-powered news
Tom Hardy was dismissed from the Paramount+ series MobLand in May 2026. Reports cited on-set issues with executive producer Jez Butterworth, 101 Studios, and other cast members.
citizen.co.zaTom Hardy was removed from the Paramount+ series MobLand after two seasons in May 2026. Reports attributed the decision to on-set issues involving executive producer Jez Butterworth, 101 Studios, and other participants. A Puck News report stated that Hardy arrived late to production during Season 2, offered frequent script notes, altered dialogue, and expressed dissatisfaction with the ensemble cast that included Helen Mirren and Pierce Brosnan.
Camera operator Mark Goellnicht described an incident on the 2015 film Mad Max: Fury Road. m. call time, then confronted him about the delay. Goellnicht stated that Theron requested a producer remain with her for protection after the exchange. Theron later said she did not feel safe during the production.
Director John Hillcoat told Collider that Hardy and Shia LaBeouf fought on the set of the 2012 film Lawless and had to be restrained. LaBeouf disputed accounts that he knocked Hardy unconscious, describing the interaction as rough-housing. Patrick Stewart wrote in his 2023 memoir that Hardy remained in his trailer and did not greet cast members during the 2002 film Star Trek: Nemesis.
Hardy told Total Film in 2014 that he felt out of his depth on that production.
Single source — no framing comparison available.
A 26-year-old Colombian national was fatally shot in Biddeford on Monday. The incident prompted federal officials to suspend most vehicle stops nationwide after two recent deaths.
Al JazeeraSix officers were buried at al-Shifa Hospital in Gaza City on July 14. The death toll since the October ceasefire reached 1,108, with cumulative figures since 2023 at 73,231 killed.
Japan TimesThe University of Oxford has started an early-stage clinical trial of a vaccine targeting the Bundibugyo strain of Ebola. The trial will enroll 50 healthy adults to test safety and immune response.